Hemostatic profile changes in patients with traumatic brain injury with regard to the genotypes of -675 4G/5G polymorphism of plasminogen activator inhibitor-1 gene
DOI:
https://doi.org/10.14739/2310-1210.2016.2.69233Keywords:
Traumatic Brain Injury, Hemostasis, Profile, Genetic Rolymorphism, Plasminogen Activator Inhibitor 1Abstract
Traumatic brain injury (TBI) is a significant problem in modern clinical medicine that has both medical and social importance. Analysis of hemostatic changes is a very important aspect of clinical course of TBI and should be paid special attention on it. This analysis is necessary to make prognosis for the treatment outcomes taking into account associations with genetic factors.
The aim of research was to analyze hemostatic profile changes in patients with TBI with regard to the genotype of -675 4G/5G polymorphism of plasminogen activator inhibitor-1 gene (РАІ-1).
Methods and materials. The research was based on the investigation results of 200 patients with isolated TBI, who were undergoing in-patient treatment at the neurosurgery department at Sumy Regional Clinical Hospital in 2011–2013, and 95 apparently healthy individuals of the control group.
The following change cycling was confirmed during the study: a tendency to hypercoagulability on the 1st day transforming into a state of being incapable of coagulation on the 3rd day. On the 7 day hypercoagulability signs dominated and by the 14 day the laboratory findings had gradually become normal.
Conclusions. According to the analysis of routine hemostatic profile parameters (activated partial thromboplastin time, prothrombin index, platelet count, plasma tolerance to heparin, activated recalcification time, euglobulin clot lysis assay, plasma fibrinogen level) we concluded that there is no association between the studied parameters and the genotypes of the -675 4G/5G polymorphism in the PAI-1 gene in patients with TBI and controls. Our study confirms the necessity of further monitoring of fibrinolytic system, since routine laboratory tests of haemostasis are not always informative as for the fibrinolytic disorders in patients with TBI.
References
Huk, A. P. (2013) Epidemiolohiia cherepno-mozkovoi travmy v Ukraini [Epidemiology of traumatic brain injury in Ukraine]. Proceedings of 5th Congress of Neurosurgeons of Ukraine. Uzhgorod. [In Ukrainian].
Vasiliev, S. A., & Vinogradov, V. L. (2007) Rol' nasledstvennosti v razvitii trombozov [Role of heredity in thrombosis development]. Tromboz, gemostaz i reologija, 3, 32–40. [in Russian].
Khan, S., & Dickerman, J. D. (2006) Hereditary thrombophilia. Thromb. J., 4, 15–38. doi: 10.1186/1477-9560-4-15.
Balta, G., Altay, C., & Gurgey, A. (2002) PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am. J. Hematol., 71(2), 89–93.
Kozlov, A. A., Natrus, L. V., Chernovol, P. A., et al. (2011) Laboratornaya diagnostika sistemy gemostaza [Laboratory diagnosis of hemostatic system]. Мoscow: Litterra. [in Russian].
Kozlov, A. A., Berkovskij, A. L., Kachalova, N. D. (2013) Posobiie dlya vrachej-laborantov po metodam issledovaniya plazmennogo gemostaza. Protivosvertyvayushchaya sistema. Sistema fibrinoliza [Manual for laboratory doctors on plasma hemostasis research methods. Anticoagulation system. Fibrinolysis system]. Мoscow: Print Publ. [in Russian].
Akhunbejli, A. A., Ragimov, V. S., Fatullaeva, A. A. (2010) Izmeneniya sistemy gemostaza i aktivnosti 5-nukleotidazy v krovi u bol'nykh v ostrom periode posle ushiba golovnogo mozga [Changes of hemostasis system and activity of 5-nucleotidase in the blood of patients during an acute period after the brain contusion]. Klinichna khirurhiia, 7, 37–40. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)